Agendia Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer Premium The firm envisions marketing the 53-gene signature with its existing MammaPrint and BluePrint tests as a comprehensive platform for breast cancer treatment selection. People in the News: New Appointments at Agendia, Seegene, Illumina, More Agendia Offering AI-Enabled Genomic Test for Breast Cancer in Brazil as it Eyes Global Market Premium The firm is offering access in Brazil to a digital assay that provides genomic insights using technology developed in a collaboration with computational pathology firm Paige. Agendia to Distribute Inivata Liquid Biopsy Breast Cancer Test in North America, Europe Agendia will receive co-exclusive rights to distribute Inivata's RaDaR assay for minimal residual disease and relapse detection in Europe and North America. Agendia FLEX Registry Powers Genomics Research on Underrepresented Breast Cancer Patients Premium FLEX will include full transcriptome data paired with 800 data points from 10,000 patients, offering researchers the chance to study diverse patient subsets. Nov 18, 2020 Agendia, Paige Partner to Codevelop New Assays Using MammaPrint, BluePrint Signatures Oct 15, 2020 Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests Oct 6, 2020 PathoNext to Offer Agendia's Breast Cancer Recurrence Assays in Germany Aug 26, 2020 Agendia's MammaPrint Breast Cancer Risk Test Cost-Effective in Multi-Country Analysis Jul 2, 2020 Agendia Settles Allegations of Medicare Fraud for $8.25M Jun 12, 2020 New Data Support Role of Agendia BluePrint Test in Refining Breast Cancer Subtypes Premium May 21, 2019 Agendia, Imegen Ink Distribution Deal for Breast Cancer Tests in Spain, Portugal Dec 19, 2018 Breast Cancer Molecular Tests Included in Recommendations by UK's NICE Dec 10, 2018 SABCS 2018 Features Molecular Diagnostics Research Nov 16, 2018 Agendia Breast Cancer Tests Show Promise for Improved Therapy Prediction Premium Oct 10, 2018 NCCN Update on Breast Cancer Genetic Testing Guidelines Marks Oncotype DX as 'Preferred' Test Sep 18, 2018 Agendia Partners With GeneCast to Launch Tests in China Aug 24, 2018 In Brief This Week: MolecularMD, Agendia, Promega, NRGene, More Jul 25, 2018 Agendia Secures $35M Investment May 24, 2018 Agendia Inks Southeast Asian Marketing Deal for Breast Cancer Tests May 15, 2018 Agendia Breast Cancer Tests Adopted by French Hospital Group May 1, 2018 Aetna, Cigna, UnitedHealthcare to Cover Agendia's MammaPrint Apr 5, 2018 Agendia Moving to Decentralized Testing Model in Europe, Exploring Options for Asia Expansion Premium Mar 21, 2018 Agendia NGS MammaPrint BluePrint Kit Receives CE Mark Feb 7, 2018 UK's NICE Finalizing Updated Breast Cancer Test Guidance Following Stakeholder Comments Premium Load More Breaking News Bio-Rad Laboratories, Cytek Biosciences Partner on Flow Cytometry Reagents Tecan Inks Deals for NGS Library Prep System With Element Biosciences, Singular Genomics Genomenon, Flagship Biosciences Partner on Biomarker Discovery, Companion Dx Development Velsera to Integrate Arima Genomics Gene Fusion Test in Pierian Clinical Platform Evonetix Raises $24M in Extended Series B Funding Round The Scan Study Points to Tuberculosis Protection by Gaucher Disease Mutation A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds. SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource. Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages. UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.